Drug recall
Apheresis Granulocytes
FDA recall event 82408 · Class II · OneBlood, Inc.
Key facts
| Event ID | 82408 |
|---|---|
| Recall numbers | B-0458-2019 |
| Recalling firm | OneBlood, Inc. |
| Product type | Biologics |
| Products | Apheresis Granulocytes |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood products, with a low granulocyte yield, were distributed. |
| Initiation date | Jan 18, 2019 |
| Report date | Apr 10, 2019 |
| Termination date | Apr 1, 2019 |
| City | St Petersburg |
| State | FL |
| Country | United States |
| FEI number | 1070196 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: